Artificial Intelligence Passes Macular Degeneration Test

Share - whatsappTelegramEmailFacebookGoogleLinkedInPrintRedditTwitter

AMD is a common retinal pathology where patients are not aware until vision gets compromised. With less no of retinal specialist, it’s a difficult job to screen every one in early stages. But with the help of artificial intelligence even general practitioners can detect it. Recently iHealthScreen has developed a new artificial intelligence system, iPredict for screening patients with AMD. Its showing promising results in clinical trials. Alauddin and colleagues has used AREDS dataset to determine the accuracy, weather its comparable to human retina specialist. 

"We are delighted to say that the tool is now ready for clinical use and potential remote telemedical deployment," said Sharmina Alauddin, MBBS, from New York Eye and Ear Infirmary of Mount Sinai Hospital in New York City.